CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like Receptors (TLR), today announced that it will discuss its drug discovery and development programs and provide a general corporate overview at the Cowen and Company 30th Annual Health Care Conference on Tuesday, March 9, at 3:00 p.m. EST at the Boston Marriott Copley Place in Boston, MA.
